back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-02-10 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Harris, Robert Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-2,169,135 vol |
0 | |
| Filed 2016-02-10 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-210,000 vol |
0 | |
| Filed 2016-02-10 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Clarke, Janice
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-299,165 vol |
0 | |
| Filed 2016-02-08 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-12,691,025 vol |
0 | |
| Filed 2016-02-08 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-4,700,000 vol |
0 | |
| Filed 2016-02-05 Tx date 2016-02-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-399.00
-300 vol $1.33 each |
12,686,625 | |
| Filed 2016-02-05 Tx date 2016-02-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,132
+11,700 vol $1.29 each |
12,686,925 | |
| Filed 2016-02-05 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Harris, Robert Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-5,062,500 vol |
0 | |
| Filed 2016-02-05 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Harris, Mary-Ann
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-4,125,000 vol |
0 | |
| Filed 2016-02-05 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Clarke, Janice
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-80,422 vol |
0 | |
| Filed 2016-02-05 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Clarke, Janice
5 - Senior Officer of Issuer
Holder: Eugene Clarke (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-10,000 vol |
0 | |
| Filed 2016-02-05 Tx date 2016-02-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,965
+6,900 vol $1.30 each |
12,699,925 | |
| Filed 2016-02-05 Tx date 2016-02-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,616.28
-8,900 vol $1.31 each |
12,691,025 | |
| Filed 2016-02-05 Tx date 2016-02-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,344.22
-11,300 vol $1.27 each |
12,693,025 | |
| Filed 2016-02-05 Tx date 2016-02-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,815
+17,700 vol $1.29 each |
12,704,325 | |
| Filed 2016-01-29 Tx date 2016-01-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,225.90
-5,500 vol $1.31 each |
12,490,025 | |
| Filed 2016-01-29 Tx date 2016-01-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,022
+19,400 vol $1.29 each |
12,675,225 | |
| Filed 2016-01-29 Tx date 2016-01-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,311.87
-18,700 vol $1.30 each |
12,655,825 | |
| Filed 2016-01-29 Tx date 2016-01-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,806
+2,200 vol $1.28 each |
12,674,525 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-411.00
-300 vol $1.37 each |
12,672,325 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,910
+7,400 vol $1.34 each |
12,672,625 | |
| Filed 2016-01-29 Tx date 2016-01-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$233,681
+175,200 vol $1.33 each |
12,665,225 | |
| Filed 2016-01-29 Tx date 2016-01-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,493
+5,700 vol $1.31 each |
12,495,525 | |
| Filed 2016-01-24 Tx date 2016-01-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,331.14
-4,300 vol $1.24 each |
12,472,025 | |
| Filed 2016-01-24 Tx date 2016-01-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-127.00
-100 vol $1.27 each |
12,489,825 | |
| Filed 2016-01-24 Tx date 2016-01-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,833
+17,900 vol $1.28 each |
12,489,925 | |
| Filed 2016-01-24 Tx date 2016-01-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,177
+9,900 vol $1.23 each |
12,476,325 | |
| Filed 2016-01-24 Tx date 2016-01-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-366.00
-300 vol $1.22 each |
12,466,425 | |
| Filed 2016-01-24 Tx date 2016-01-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,686
+22,900 vol $1.25 each |
12,466,725 | |
| Filed 2016-01-24 Tx date 2016-01-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,647
+20,600 vol $1.25 each |
12,443,825 | |
| Filed 2016-01-24 Tx date 2016-01-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$90,337
+75,100 vol $1.20 each |
12,423,225 | |
| Filed 2016-01-15 Tx date 2016-01-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,804.40
-82,200 vol $1.20 each |
12,163,825 | |
| Filed 2016-01-15 Tx date 2016-01-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,692
+38,400 vol $1.24 each |
12,348,125 | |
| Filed 2016-01-15 Tx date 2016-01-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-65,985.40
-53,300 vol $1.24 each |
12,309,725 | |
| Filed 2016-01-15 Tx date 2016-01-13 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,929
-4,900 vol $1.21 each |
12,363,025 | |
| Filed 2016-01-15 Tx date 2016-01-13 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,064
+7,800 vol $1.16 each |
12,367,925 | |
| Filed 2016-01-15 Tx date 2016-01-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,093
+16,400 vol $1.23 each |
12,360,125 | |
| Filed 2016-01-15 Tx date 2016-01-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,958.40
-1,600 vol $1.22 each |
12,343,725 | |
| Filed 2016-01-15 Tx date 2016-01-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$216,130
+181,500 vol $1.19 each |
12,345,325 | |
| Filed 2016-01-11 Tx date 2016-01-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-966.00
-700 vol $1.38 each |
12,426,225 | |
| Filed 2016-01-11 Tx date 2016-01-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,730.31
-40,900 vol $1.22 each |
12,246,025 | |
| Filed 2016-01-11 Tx date 2016-01-07 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-193,552.74
-152,200 vol $1.27 each |
12,286,925 | |
| Filed 2016-01-11 Tx date 2016-01-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,820
-31,400 vol $1.30 each |
12,439,125 | |
| Filed 2016-01-11 Tx date 2016-01-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,908
+44,300 vol $1.31 each |
12,470,525 | |
| Filed 2016-01-11 Tx date 2016-01-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,818
+10,500 vol $1.32 each |
12,426,925 | |
| Filed 2015-12-31 Tx date 2015-12-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,919
+38,500 vol $1.30 each |
12,163,325 | |
| Filed 2015-12-31 Tx date 2015-12-31 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$125,485
+93,800 vol $1.34 each |
12,416,425 | |
| Filed 2015-12-31 Tx date 2015-12-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$121,418
+97,400 vol $1.25 each |
12,093,525 | |
| Filed 2015-12-31 Tx date 2015-12-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,512
+17,800 vol $1.32 each |
12,322,625 | |
| Filed 2015-12-31 Tx date 2015-12-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$170,112
+132,600 vol $1.28 each |
12,304,825 | |
| Filed 2015-12-31 Tx date 2015-12-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,335
+8,900 vol $1.27 each |
12,172,225 | |
| Filed 2015-12-31 Tx date 2015-12-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,303
+31,300 vol $1.26 each |
12,124,825 | |
| Filed 2015-12-22 Tx date 2015-12-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,332
+38,600 vol $1.12 each |
11,958,525 | |
| Filed 2015-12-22 Tx date 2015-12-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,160
+25,200 vol $1.28 each |
11,996,125 | |
| Filed 2015-12-22 Tx date 2015-12-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,044
+12,400 vol $1.29 each |
11,970,925 | |
| Filed 2015-12-22 Tx date 2015-12-14 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,204
+5,400 vol $1.15 each |
11,919,925 | |
| Filed 2015-12-13 Tx date 2015-12-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$124,747
+100,700 vol $1.24 each |
11,915,525 | |
| Filed 2015-12-13 Tx date 2015-12-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$64,592
+49,300 vol $1.31 each |
11,814,825 | |
| Filed 2015-12-13 Tx date 2015-12-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,210
-1,000 vol $1.21 each |
11,914,525 | |
| Filed 2015-12-10 Tx date 2015-12-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$254,367
+193,200 vol $1.32 each |
11,693,625 | |
| Filed 2015-12-10 Tx date 2015-11-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,580.90
-3,800 vol $1.21 each |
11,500,425 | |
| Filed 2015-12-10 Tx date 2015-11-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,134
+34,900 vol $1.21 each |
11,504,225 | |
| Filed 2015-12-10 Tx date 2015-12-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,077
+38,000 vol $1.42 each |
11,765,525 | |
| Filed 2015-12-10 Tx date 2015-12-02 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,280
+33,900 vol $1.34 each |
11,727,525 | |
| Filed 2015-11-27 Tx date 2015-11-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,580
+6,000 vol $1.10 each |
11,469,325 | |
| Filed 2015-11-20 Tx date 2015-11-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,162.90
-20,500 vol $1.37 each |
11,439,125 | |
| Filed 2015-11-20 Tx date 2015-11-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,092.38
-26,900 vol $1.23 each |
11,463,325 | |
| Filed 2015-11-20 Tx date 2015-11-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,321
+28,200 vol $1.00 each |
11,490,225 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,273
+22,900 vol $1.32 each |
11,462,025 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,567.09
-1,900 vol $1.35 each |
11,459,625 | |
| Filed 2015-11-13 Tx date 2015-11-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,838
+51,400 vol $1.28 each |
11,375,525 | |
| Filed 2015-11-13 Tx date 2015-11-13 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,590
+17,700 vol $1.33 each |
11,461,525 | |
| Filed 2015-11-13 Tx date 2015-11-13 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,168.94
-2,300 vol $1.38 each |
11,443,825 | |
| Filed 2015-11-13 Tx date 2015-11-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,800
+4,000 vol $1.20 each |
11,446,125 | |
| Filed 2015-11-13 Tx date 2015-11-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-768.00
-600 vol $1.28 each |
11,442,125 | |
| Filed 2015-11-13 Tx date 2015-11-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,523
+55,600 vol $1.14 each |
11,442,725 | |
| Filed 2015-11-13 Tx date 2015-11-10 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,454
+11,600 vol $1.16 each |
11,387,125 | |
| Filed 2015-11-13 Tx date 2015-11-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,250
-25,000 vol $1.29 each |
11,324,125 | |
| Filed 2015-11-06 Tx date 2015-11-02 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,919.04
-9,400 vol $1.16 each |
11,316,525 | |
| Filed 2015-11-06 Tx date 2015-11-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-5,000 vol $1.20 each |
11,349,125 | |
| Filed 2015-11-06 Tx date 2015-11-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,854
+7,400 vol $1.20 each |
11,354,125 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,220
+2,000 vol $1.11 each |
11,346,725 | |
| Filed 2015-11-06 Tx date 2015-11-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,025
+28,200 vol $1.10 each |
11,344,725 | |
| Filed 2015-10-30 Tx date 2015-10-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,821
-2,500 vol $1.13 each |
11,326,625 | |
| Filed 2015-10-30 Tx date 2015-10-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,005.55
-10,300 vol $1.07 each |
11,329,125 | |
| Filed 2015-10-30 Tx date 2015-10-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,699.20
-16,000 vol $1.11 each |
11,339,425 | |
| Filed 2015-10-30 Tx date 2015-10-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-763.00
-700 vol $1.09 each |
11,325,925 | |
| Filed 2015-10-26 Tx date 2015-10-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,557
+36,200 vol $1.04 each |
11,317,825 | |
| Filed 2015-10-26 Tx date 2015-10-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,179
+3,600 vol $1.16 each |
11,259,225 | |
| Filed 2015-10-26 Tx date 2015-10-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,289
+22,400 vol $1.13 each |
11,281,625 | |
| Filed 2015-10-26 Tx date 2015-10-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$214.00
+200 vol $1.07 each |
11,355,425 | |
| Filed 2015-10-26 Tx date 2015-10-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,111
+43,000 vol $1.05 each |
11,355,225 | |
| Filed 2015-10-26 Tx date 2015-10-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,947.76
-5,600 vol $1.06 each |
11,312,225 | |
| Filed 2015-10-16 Tx date 2015-10-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,747.88
-62,800 vol $1.22 each |
11,214,125 | |
| Filed 2015-10-16 Tx date 2015-10-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,783
+41,500 vol $1.18 each |
11,255,625 | |
| Filed 2015-10-16 Tx date 2015-10-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,506
+2,200 vol $1.14 each |
11,276,925 | |
| Filed 2015-10-09 Tx date 2015-09-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$256,038
+241,000 vol $1.06 each |
11,357,425 | |
| Filed 2015-10-09 Tx date 2015-10-07 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,219
-2,900 vol $1.11 each |
11,274,725 | |
| Filed 2015-10-09 Tx date 2015-10-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,214.14
-5,700 vol $1.09 each |
11,277,625 | |
| Filed 2015-10-09 Tx date 2015-10-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,547.78
-71,700 vol $1.12 each |
11,283,325 | |
| Filed 2015-10-09 Tx date 2015-09-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307,378
+290,500 vol $1.06 each |
||
| Filed 2015-10-06 Tx date 2015-09-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,235.81
-33,900 vol $1.13 each |
11,116,425 | |
| Filed 2015-10-06 Tx date 2015-10-02 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,300
+3,000 vol $1.10 each |
11,404,525 | |
| Filed 2015-10-06 Tx date 2015-10-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,363.75
-37,500 vol $1.05 each |
11,401,525 | |
| Filed 2015-10-06 Tx date 2015-10-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,360
+32,100 vol $1.01 each |
11,439,025 | |
| Filed 2015-10-06 Tx date 2015-09-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$162,382
+149,400 vol $1.09 each |
11,150,325 | |
| Filed 2015-10-06 Tx date 2015-09-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-322,707.36
-281,300 vol $1.15 each |
11,000,925 | |
| Filed 2015-10-06 Tx date 2015-09-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,536.14
-102,900 vol $1.34 each |
11,282,225 | |
| Filed 2015-10-06 Tx date 2015-09-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,540
+2,000 vol $1.27 each |
11,385,125 | |
| Filed 2015-10-06 Tx date 2015-09-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307,378
+290,500 vol $1.06 each |
11,406,925 | |
| Filed 2015-09-25 Tx date 2015-09-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,328.28
-26,800 vol $1.54 each |
11,487,125 | |
| Filed 2015-09-25 Tx date 2015-09-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,420
+2,000 vol $1.71 each |
11,566,825 | |
| Filed 2015-09-25 Tx date 2015-09-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-79,967.74
-43,100 vol $1.86 each |
11,523,725 | |
| Filed 2015-09-25 Tx date 2015-09-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-73,648.75
-44,300 vol $1.66 each |
11,479,425 | |
| Filed 2015-09-25 Tx date 2015-09-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,887
+25,000 vol $1.60 each |
11,504,425 | |
| Filed 2015-09-25 Tx date 2015-09-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,025
-8,500 vol $1.65 each |
11,495,925 | |
| Filed 2015-09-25 Tx date 2015-09-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,180
+18,000 vol $1.51 each |
11,513,925 | |
| Filed 2015-09-25 Tx date 2015-09-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-153,483.20
-104,000 vol $1.48 each |
11,383,125 | |
| Filed 2015-09-21 Tx date 2015-09-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,745
-1,500 vol $1.83 each |
11,564,825 | |
| Filed 2015-09-21 Tx date 2015-09-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,600.92
-1,400 vol $1.86 each |
11,566,325 | |
| Filed 2015-09-21 Tx date 2015-09-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,879.02
-50,200 vol $1.87 each |
11,567,725 | |
| Filed 2015-09-21 Tx date 2015-09-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,668
+8,100 vol $1.81 each |
11,617,925 | |
| Filed 2015-09-21 Tx date 2015-09-14 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,189.14
-5,300 vol $1.73 each |
11,609,825 | |
| Filed 2015-09-21 Tx date 2015-09-14 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,147
+7,800 vol $1.69 each |
11,615,125 | |
| Filed 2015-09-11 Tx date 2015-09-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,524
+2,900 vol $1.56 each |
11,489,425 | |
| Filed 2015-09-11 Tx date 2015-09-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,186.44
-23,900 vol $1.64 each |
11,465,525 | |
| Filed 2015-09-11 Tx date 2015-09-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,937
+59,500 vol $1.65 each |
11,607,325 | |
| Filed 2015-09-11 Tx date 2015-09-10 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,316
-6,900 vol $1.64 each |
11,547,825 | |
| Filed 2015-09-11 Tx date 2015-09-10 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$146,879
+92,400 vol $1.59 each |
11,554,725 | |
| Filed 2015-09-11 Tx date 2015-09-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,422.40
-12,800 vol $1.60 each |
11,462,325 | |
| Filed 2015-09-11 Tx date 2015-09-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,456
+9,600 vol $1.61 each |
11,475,125 | |
| Filed 2015-09-09 Tx date 2015-08-31 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,861.95
-16,700 vol $1.61 each |
11,465,025 | |
| Filed 2015-09-09 Tx date 2015-09-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,760
-25,000 vol $1.55 each |
11,486,525 | |
| Filed 2015-09-09 Tx date 2015-09-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,379.38
-14,900 vol $1.64 each |
11,511,525 | |
| Filed 2015-09-09 Tx date 2015-09-03 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41,500
+25,000 vol $1.66 each |
11,526,425 | |
| Filed 2015-09-09 Tx date 2015-09-02 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,937
+26,900 vol $1.60 each |
11,501,425 | |
| Filed 2015-09-09 Tx date 2015-09-01 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,820
+9,500 vol $1.56 each |
11,474,525 | |
| Filed 2015-09-09 Tx date 2015-08-31 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,540
+6,000 vol $1.59 each |
11,481,725 | |
| Filed 2015-09-03 Tx date 2015-02-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
SJ Strategic Investments LLC
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$312,500
+625,000 vol $0.50 each |
||
| Filed 2015-09-03 Tx date 2013-03-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
SJ Strategic Investments LLC
3 - 10% Security Holder of Issuer
Direct Ownership
|
Series B Warrant
11 - Acquisition or disposition carried out privately
|
+625,000 vol |
625,000 | |
| Filed 2015-09-03 Tx date 2013-03-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
SJ Strategic Investments LLC
3 - 10% Security Holder of Issuer
Direct Ownership
|
Series B Warrant
11 - Acquisition or disposition carried out privately
|
+625,000 vol |
||
| Filed 2015-09-03 Tx date 2015-02-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
SJ Strategic Investments LLC
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$312,500
+625,000 vol $0.50 each |
7,063,794 | |
| Filed 2015-09-02 Tx date 2015-02-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Gregory, John Maness
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Kingsway Charities, Inc. (Control or Direction)
|
Series B Warrant
90 - Change in the nature of ownership
|
-312,500 vol |
0 | |
| Filed 2015-09-02 Tx date 2015-02-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Gregory, John Maness
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Kingsway Charities, Inc. (Control or Direction)
|
Common Shares
90 - Change in the nature of ownership
|
-1,337,500 vol |
0 | |
| Filed 2015-08-28 Tx date 2015-08-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,667
+19,300 vol $1.59 each |
11,475,725 | |
| Filed 2015-08-28 Tx date 2015-08-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,464.02
-36,600 vol $1.62 each |
11,456,425 | |
| Filed 2015-08-28 Tx date 2015-08-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,800
+68,000 vol $1.60 each |
11,493,025 | |
| Filed 2015-08-28 Tx date 2015-08-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-72,530.47
-45,700 vol $1.59 each |
11,425,025 | |
| Filed 2015-08-28 Tx date 2015-08-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$71,495
+50,000 vol $1.43 each |
11,470,725 | |
| Filed 2015-08-28 Tx date 2015-08-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-45,023.48
-29,200 vol $1.54 each |
11,420,725 | |
| Filed 2015-08-26 Tx date 2015-08-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,760
-12,800 vol $1.70 each |
11,347,325 | |
| Filed 2015-08-26 Tx date 2015-08-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-136,889.57
-84,100 vol $1.63 each |
11,360,125 | |
| Filed 2015-08-26 Tx date 2015-08-13 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,886.50
-46,500 vol $1.76 each |
11,444,225 | |
| Filed 2015-08-26 Tx date 2015-08-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,317.60
-21,100 vol $1.82 each |
11,490,725 | |
| Filed 2015-08-26 Tx date 2015-08-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,017
+8,900 vol $1.80 each |
11,511,825 | |
| Filed 2015-08-26 Tx date 2015-08-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,474.68
-15,600 vol $1.83 each |
11,502,925 | |
| Filed 2015-08-26 Tx date 2015-08-07 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,112.98
-12,700 vol $1.98 each |
11,518,525 | |
| Filed 2015-08-26 Tx date 2015-08-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-174,431.50
-83,500 vol $2.09 each |
11,531,225 | |
| Filed 2015-08-26 Tx date 2015-08-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,240.85
-6,500 vol $2.19 each |
11,607,625 | |
| Filed 2015-08-26 Tx date 2015-08-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,207
+7,100 vol $2.00 each |
11,614,725 | |
| Filed 2015-08-26 Tx date 2015-08-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-109,456.20
-73,500 vol $1.49 each |
11,449,925 | |
| Filed 2015-08-26 Tx date 2015-08-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,904
+59,000 vol $1.46 each |
11,523,425 | |
| Filed 2015-08-26 Tx date 2015-08-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$223,083
+157,500 vol $1.42 each |
11,464,425 | |
| Filed 2015-08-26 Tx date 2015-08-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,012.80
-33,600 vol $1.55 each |
11,306,925 | |
| Filed 2015-08-26 Tx date 2015-08-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,732
+55,600 vol $1.49 each |
11,340,525 | |
| Filed 2015-08-26 Tx date 2015-08-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,000
-25,000 vol $1.56 each |
11,284,925 | |
| Filed 2015-08-26 Tx date 2015-08-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,121.40
-37,400 vol $1.66 each |
11,309,925 | |
| Filed 2015-07-31 Tx date 2015-07-29 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$363,013
+174,400 vol $2.08 each |
11,364,025 | |
| Filed 2015-07-31 Tx date 2015-07-31 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$630.00
+300 vol $2.10 each |
11,614,125 | |
| Filed 2015-07-31 Tx date 2015-07-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$510,416
+249,800 vol $2.04 each |
11,613,825 | |
| Filed 2015-07-31 Tx date 2015-07-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,400
-2,000 vol $2.20 each |
11,189,625 | |
| Filed 2015-07-31 Tx date 2015-07-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,189
+14,000 vol $2.16 each |
11,191,625 | |
| Filed 2015-07-31 Tx date 2015-07-27 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,938
+75,400 vol $2.12 each |
11,177,625 | |
| Filed 2015-07-24 Tx date 2015-07-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,284
+27,200 vol $2.07 each |
11,087,025 | |
| Filed 2015-07-24 Tx date 2015-07-20 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$157,627
+74,900 vol $2.10 each |
11,059,825 | |
| Filed 2015-07-24 Tx date 2015-07-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,248
+15,200 vol $2.06 each |
11,102,225 | |
| Filed 2015-07-20 Tx date 2015-07-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,787
+28,400 vol $2.07 each |
10,980,125 | |
| Filed 2015-07-20 Tx date 2015-07-14 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,465
+57,000 vol $1.90 each |
10,716,925 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$455,629
+234,800 vol $1.94 each |
10,951,725 | |
| Filed 2015-07-20 Tx date 2015-07-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,276.08
-4,400 vol $2.11 each |
10,984,925 | |
| Filed 2015-07-20 Tx date 2015-07-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,676
+9,200 vol $2.03 each |
10,989,325 | |
| Filed 2015-07-13 Tx date 2015-07-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$534,980
+295,700 vol $1.81 each |
10,263,125 | |
| Filed 2015-07-13 Tx date 2015-07-10 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$537,871
+299,000 vol $1.80 each |
10,659,925 | |
| Filed 2015-07-13 Tx date 2015-07-09 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$178,230
+97,800 vol $1.82 each |
10,360,925 | |
| Filed 2015-07-13 Tx date 2015-07-07 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$605,015
+336,400 vol $1.80 each |
9,967,425 | |
| Filed 2015-07-03 Tx date 2015-07-02 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,365
+4,300 vol $1.95 each |
9,631,025 | |
| Filed 2015-07-03 Tx date 2015-06-30 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,700
+2,000 vol $1.85 each |
9,626,725 | |
| Filed 2015-06-26 Tx date 2015-06-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-90,000 vol |
||
| Filed 2015-06-26 Tx date 2015-06-26 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$278,556
+148,200 vol $1.88 each |
9,624,725 | |
| Filed 2015-06-26 Tx date 2015-06-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,317
+29,700 vol $1.90 each |
9,476,525 | |
| Filed 2015-06-26 Tx date 2015-06-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$203,837
+101,200 vol $2.01 each |
9,446,825 | |
| Filed 2015-06-26 Tx date 2015-06-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-208,746.72
-93,600 vol $2.23 each |
9,345,625 | |
| Filed 2015-06-26 Tx date 2015-06-23 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$351,333
+170,600 vol $2.06 each |
9,439,225 | |
| Filed 2015-06-26 Tx date 2015-06-22 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-405,438.75
-184,500 vol $2.20 each |
9,268,625 | |
| Filed 2015-06-26 Tx date 2010-07-01 |
$TRX
Stellar Pharmaceuticals Inc. |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,500
+90,000 vol $0.95 each |
145,000 | |
| Filed 2015-06-26 Tx date 2010-07-01 |
$TRX
Stellar Pharmaceuticals Inc. |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,500
+90,000 vol $0.95 each |
||
| Filed 2015-06-26 Tx date 2015-06-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-90,000 vol |
||
| Filed 2015-06-25 Tx date 2015-06-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-90,000 vol |
145,000 | |
| Filed 2015-06-25 Tx date 2015-06-25 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Kime, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-25,000 vol |
120,000 | |
| Filed 2015-06-22 Tx date 2015-06-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$162,295
+94,600 vol $1.72 each |
9,214,625 | |
| Filed 2015-06-22 Tx date 2015-06-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-506,049.56
-255,400 vol $1.98 each |
9,453,125 | |
| Filed 2015-06-22 Tx date 2015-06-19 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$301,005
+150,300 vol $2.00 each |
9,708,525 | |
| Filed 2015-06-22 Tx date 2015-06-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-138,588.84
-70,200 vol $1.97 each |
9,558,225 | |
| Filed 2015-06-22 Tx date 2015-06-18 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$514,992
+269,700 vol $1.91 each |
9,628,425 | |
| Filed 2015-06-22 Tx date 2015-06-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$693,763
+374,400 vol $1.85 each |
9,358,725 | |
| Filed 2015-06-22 Tx date 2015-06-17 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-140,544
-76,800 vol $1.83 each |
8,984,325 | |
| Filed 2015-06-22 Tx date 2015-06-16 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-267,581.20
-153,500 vol $1.74 each |
9,061,125 | |
| Filed 2015-06-12 Tx date 2015-06-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,250
-75,000 vol $1.43 each |
8,162,725 | |
| Filed 2015-06-12 Tx date 2015-06-12 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$994,677
+662,500 vol $1.50 each |
9,120,025 | |
| Filed 2015-06-12 Tx date 2015-06-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$427,371
+294,800 vol $1.45 each |
8,457,525 | |
| Filed 2015-06-12 Tx date 2015-06-10 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307,364
+213,700 vol $1.44 each |
8,237,725 | |
| Filed 2015-06-09 Tx date 2015-06-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,024,025 | ||
| Filed 2015-06-09 Tx date 2015-06-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
4,700,000 | ||
| Filed 2015-05-22 Tx date 2015-05-21 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,843.85
-25,500 vol $1.05 each |
6,499,625 | |
| Filed 2015-05-12 Tx date 2015-05-11 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,331.39
-7,300 vol $1.00 each |
6,525,125 | |
| Filed 2015-05-12 Tx date 2015-05-08 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-73,501.70
-74,500 vol $0.99 each |
6,532,425 | |
| Filed 2015-05-08 Tx date 2015-05-04 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,760
-8,000 vol $0.97 each |
6,712,425 | |
| Filed 2015-05-08 Tx date 2015-05-07 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,333
-29,000 vol $0.98 each |
6,606,925 | |
| Filed 2015-05-08 Tx date 2015-05-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,669.25
-99,500 vol $0.96 each |
6,635,925 | |
| Filed 2015-05-08 Tx date 2015-05-06 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+500 vol $0.90 each |
6,735,425 | |
| Filed 2015-05-08 Tx date 2015-05-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,250
+22,500 vol $0.90 each |
6,734,925 | |
| Filed 2015-05-04 Tx date 2015-04-28 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-201,188.32
-203,200 vol $0.99 each |
6,720,425 | |
| Filed 2015-04-28 Tx date 2015-04-24 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,349.85
-64,700 vol $1.03 each |
6,923,625 |